Combination PPARγ and RXR Agonist Treatment in Melanoma Cells: Functional Importance of S100A2

Nuclear hormone receptors, including RXR and PPARγ, represent novel therapeutic targets in melanoma. We have previously shown that the DRO subline of the amelanotic melanoma A375 responds to rexinoid and thiazolidinedione (TZD) treatment in vitro and in vivo. We performed microarray analysis of A375...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Klopper, Joshua P., Sharma, Vibha, Bissonnette, Reid, Haugen, Bryan R.
Format: Artigo
Idioma:Inglês
Publicat: Hindawi Publishing Corporation 2010
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2763133/
https://ncbi.nlm.nih.gov/pubmed/19859558
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2010/729876
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars